{"product_id":"american-diabetes-association-85th-scientific-sessions-2025","title":"American Diabetes Association 85th Scientific Sessions 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: endocrinologists, diabetes researchers, primary care providers\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eWARNING: Duplicate videos removed\u003c\/p\u003e\n\u003cp\u003eAmerican Diabetes Association – 85th Scientific Sessions 2025\u003c\/p\u003e\n\u003cp\u003eThe World’s Premier Conference on Diabetes Science, Care \u0026amp; Innovation\u003c\/p\u003e\n\u003cp\u003eWhat You’ll Gain\u003c\/p\u003e\n\u003cp\u003eAccess to 200+ live sessions, including symposia, panel discussions, debates, poster presentations, and “Ask the Expert” formats—covering basic science to clinical practice\u003c\/p\u003e\n\u003cp\u003eCutting-edge content in GLP‑1 and GIP therapies, beta cell regeneration, diabetes technology, obesity and metabolic health, cardiovascular risk management, and maternal and pediatric diabetes\u003c\/p\u003e\n\u003cp\u003eInnovative sessions on AI, predictive modeling, data-driven analytics, and the ADA Innovation Challenge showcasing emerging startups transforming diabetes care\u003c\/p\u003e\n\u003cp\u003ePatient-impact stories and advocacy insights—featuring high-profile speakers and diabetes ambassadors\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003cp\u003eEndocrinologists and diabetes specialists seeking the latest research and guidelines for patient care\u003c\/p\u003e\n\u003cp\u003ePrimary care physicians, internists, and nurse practitioners managing diabetes and metabolic disorders in general practice\u003c\/p\u003e\n\u003cp\u003eCertified diabetes educators, dietitians, pharmacists, and allied health professionals involved in comprehensive team-based care\u003c\/p\u003e\n\u003cp\u003eResearchers, scientists, and innovators presenting or exploring new ideas in diabetes technology, therapeutics, and systems of care\u003c\/p\u003e\n\u003cp\u003eMedical residents, fellows, and trainees building a foundation in diabetes management and emerging treatments\u003c\/p\u003e\n\u003cp\u003eWhy This Event Stands Out\u003c\/p\u003e\n\u003cp\u003eComprehensive multidisciplinary format—from cutting-edge research to patient storytelling and hands-on technology showcases\u003c\/p\u003e\n\u003cp\u003eIncludes the Innovation Challenge, where rising companies propose disruptive ideas and solutions in diabetes care\u003c\/p\u003e\n\u003cp\u003eMix of in-person engagement and on-demand access ensures networking, education, and flexibility after the conference\u003c\/p\u003e\n\u003cp\u003eStay Ahead in Diabetes Care\u003c\/p\u003e\n\u003cp\u003eExperience the ADA’s 85th Scientific Sessions to integrate emerging science into your clinical practice, collaborate with global experts, and help drive next-generation diabetes innovations.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA Beta Way of Looking at T1D_ Scientific Insights into Beta Cell Function in Type 1 Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eA Beta Way of Looking at T1D_ Scientific Insights into Beta Cell Function in Type 1 Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eADA Chief Executive Officer Remarks; President, Health Care \u0026amp; Education Address; and Outstanding Educator in Diabetes Award Lecture.mp3\u003c\/p\u003e\n\u003cp\u003eADA Chief Executive Officer Remarks; President, Health Care \u0026amp; Education Address; and Outstanding Educator in Diabetes Award Lecture.mp4\u003c\/p\u003e\n\u003cp\u003eADA Diabetes Care Symposium-How Do We Fix a Broken Health Care System_.mp3\u003c\/p\u003e\n\u003cp\u003eADA Diabetes Care Symposium-How Do We Fix a Broken Health Care System_.mp4\u003c\/p\u003e\n\u003cp\u003eADA Diabetes Journal Symposium-Shifting from Quantity to Quality.mp3\u003c\/p\u003e\n\u003cp\u003eADA Diabetes Journal Symposium-Shifting from Quantity to Quality.mp4\u003c\/p\u003e\n\u003cp\u003eADA Education Recognition Program (ERP)-Learning to Unlearn to Learn to Drive Innovation in Population Health Delivery, What We Know About ..mp3\u003c\/p\u003e\n\u003cp\u003eADA Education Recognition Program (ERP)-Learning to Unlearn to Learn to Drive Innovation in Population Health Delivery, What We Know About ..mp4\u003c\/p\u003e\n\u003cp\u003eADA Scholars 1.mp3\u003c\/p\u003e\n\u003cp\u003eADA Scholars 1.mp4\u003c\/p\u003e\n\u003cp\u003eADA Scholars 2.mp3\u003c\/p\u003e\n\u003cp\u003eADA Scholars 2.mp4\u003c\/p\u003e\n\u003cp\u003eAdaptation of Diabetes Technologies.mp3\u003c\/p\u003e\n\u003cp\u003eAdaptation of Diabetes Technologies.mp4\u003c\/p\u003e\n\u003cp\u003eAddressing the Residual Cardiovascular Risk in People with Diabetes and ASCVD.mp3\u003c\/p\u003e\n\u003cp\u003eAddressing the Residual Cardiovascular Risk in People with Diabetes and ASCVD.mp4\u003c\/p\u003e\n\u003cp\u003eAdjunctive Therapies to Prevent Complications in Type 1 Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eAdjunctive Therapies to Prevent Complications in Type 1 Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eAdvances and Trends in Diabetes Technology.mp3\u003c\/p\u003e\n\u003cp\u003eAdvances and Trends in Diabetes Technology.mp4\u003c\/p\u003e\n\u003cp\u003eAdvances in Neuronal and Adipose Contributors to Body Weight Maintenance.mp3\u003c\/p\u003e\n\u003cp\u003eAdvances in Neuronal and Adipose Contributors to Body Weight Maintenance.mp4\u003c\/p\u003e\n\u003cp\u003eAdvancing Care for Diabetic Kidney Disease-Top Research Abstracts.mp3\u003c\/p\u003e\n\u003cp\u003eAdvancing Care for Diabetic Kidney Disease-Top Research Abstracts.mp4\u003c\/p\u003e\n\u003cp\u003eAdvancing Diabetes Care through Technology-Insights from CGM Systems, Automated Insulin Delivery, and Digital Engagement (With Richard R. R..mp3\u003c\/p\u003e\n\u003cp\u003eAdvancing Diabetes Care through Technology-Insights from CGM Systems, Automated Insulin Delivery, and Digital Engagement (With Richard R. R..mp4\u003c\/p\u003e\n\u003cp\u003eAdvancing Effective and Equitable Treatment of Hyperglycemia in Pregnancy (With Norbert Freinkel Award Lecture).mp3\u003c\/p\u003e\n\u003cp\u003eAdvancing Effective and Equitable Treatment of Hyperglycemia in Pregnancy (With Norbert Freinkel Award Lecture).mp4\u003c\/p\u003e\n\u003cp\u003eAdvancing Hyperglycemia Management in Endogenous Hypercortisolism_ Applying CATALYST Data to Clinical Practice.mp3\u003c\/p\u003e\n\u003cp\u003eAdvancing Hyperglycemia Management in Endogenous Hypercortisolism_ Applying CATALYST Data to Clinical Practice.mp4\u003c\/p\u003e\n\u003cp\u003eAdvancing Our Understanding of Inflammation and Autoimmunity-Insights from Animal Models.mp3\u003c\/p\u003e\n\u003cp\u003eAdvancing Our Understanding of Inflammation and Autoimmunity-Insights from Animal Models.mp4\u003c\/p\u003e\n\u003cp\u003eAging and Thriving-Diabetes, Cognition, and Older Adults.mp3\u003c\/p\u003e\n\u003cp\u003eAging and Thriving-Diabetes, Cognition, and Older Adults.mp4\u003c\/p\u003e\n\u003cp\u003eApoptosis (Living, Dying, and Surviving in the Pancreatic Islet).mp3\u003c\/p\u003e\n\u003cp\u003eApoptosis (Living, Dying, and Surviving in the Pancreatic Islet).mp4\u003c\/p\u003e\n\u003cp\u003eBench to Bedside and Beyond-Bioengineering in Beta-Cell Replacement Therapy.mp3\u003c\/p\u003e\n\u003cp\u003eBench to Bedside and Beyond-Bioengineering in Beta-Cell Replacement Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eBeta-Cell Development and Postnatal Growth-The Ever-Changing Pancreatic Islet.mp3\u003c\/p\u003e\n\u003cp\u003eBeta-Cell Development and Postnatal Growth-The Ever-Changing Pancreatic Islet.mp4\u003c\/p\u003e\n\u003cp\u003eBeta-Cell Stimulus-Secretion Coupling and Metabolism-Novel Pathways Affecting Islet Hormone Secretion.mp3\u003c\/p\u003e\n\u003cp\u003eBeta-Cell Stimulus-Secretion Coupling and Metabolism-Novel Pathways Affecting Islet Hormone Secretion.mp4\u003c\/p\u003e\n\u003cp\u003eBridging the Gap-The Brain-Peripheral Nervous System Connection in Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eBridging the Gap-The Brain-Peripheral Nervous System Connection in Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eCan We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss while Preserving Lean Mass_ The BELIEVE Study of Bimagrumab + Semaglu..mp3\u003c\/p\u003e\n\u003cp\u003eCan We Improve the Quality of Weight Loss by Augmenting Fat Mass Loss while Preserving Lean Mass_ The BELIEVE Study of Bimagrumab + Semaglu..mp4\u003c\/p\u003e\n\u003cp\u003eCardiovascular Complications of Long Term Diabetes-Type 1 vs. Type 2.mp3\u003c\/p\u003e\n\u003cp\u003eCardiovascular Complications of Long Term Diabetes-Type 1 vs. Type 2.mp4\u003c\/p\u003e\n\u003cp\u003eCellular Mechanisms of Atherogenesis in Diabetes (With Edwin Bierman Award Lecture).mp3\u003c\/p\u003e\n\u003cp\u003eCellular Mechanisms of Atherogenesis in Diabetes (With Edwin Bierman Award Lecture).mp4\u003c\/p\u003e\n\u003cp\u003eCentral Regulation of Hunger Signal and Body Weight Homeostasis.mp3\u003c\/p\u003e\n\u003cp\u003eCentral Regulation of Hunger Signal and Body Weight Homeostasis.mp4\u003c\/p\u003e\n\u003cp\u003eCGM in Action-Smarter Choices, Better Balance, Lasting Impact.mp3\u003c\/p\u003e\n\u003cp\u003eCGM in Action-Smarter Choices, Better Balance, Lasting Impact.mp4\u003c\/p\u003e\n\u003cp\u003eClinical Applications of Artificial Intelligence and Diabetes Technology.mp3\u003c\/p\u003e\n\u003cp\u003eClinical Applications of Artificial Intelligence and Diabetes Technology.mp4\u003c\/p\u003e\n\u003cp\u003eClinical Deep Dive_ Unlocking the Treatment Potential of Rezdiffra.mp3\u003c\/p\u003e\n\u003cp\u003eClinical Deep Dive_ Unlocking the Treatment Potential of Rezdiffra.mp4\u003c\/p\u003e\n\u003cp\u003eClosing the Critical Care Gap_ Making Hypoglycemia Readiness Routine.mp3\u003c\/p\u003e\n\u003cp\u003eClosing the Critical Care Gap_ Making Hypoglycemia Readiness Routine.mp4\u003c\/p\u003e\n\u003cp\u003eConsensus or Controversy_ Hot Topics in Nutrition 2025.mp3\u003c\/p\u003e\n\u003cp\u003eConsensus or Controversy_ Hot Topics in Nutrition 2025.mp4\u003c\/p\u003e\n\u003cp\u003eContinuous Ketone Monitoring-Innovations and Clinical Applications.mp3\u003c\/p\u003e\n\u003cp\u003eContinuous Ketone Monitoring-Innovations and Clinical Applications.mp4\u003c\/p\u003e\n\u003cp\u003eControl-IQ+ Technology_ Advancing Patient-Centered Insulin Therapy Across Type 2, Pediatrics, and Varying Insulin Needs.mp3\u003c\/p\u003e\n\u003cp\u003eControl-IQ+ Technology_ Advancing Patient-Centered Insulin Therapy Across Type 2, Pediatrics, and Varying Insulin Needs.mp4\u003c\/p\u003e\n\u003cp\u003eControversies in Continuous Glucose Monitoring.mp3\u003c\/p\u003e\n\u003cp\u003eControversies in Continuous Glucose Monitoring.mp4\u003c\/p\u003e\n\u003cp\u003eControversies in Peripartum Management of Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eControversies in Peripartum Management of Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eCross-Sectoral Platforms-Transforming Diabetes Prevention for All.mp3\u003c\/p\u003e\n\u003cp\u003eCross-Sectoral Platforms-Transforming Diabetes Prevention for All.mp4\u003c\/p\u003e\n\u003cp\u003eDecoding Alpha- and Beta-Cell Function-Human Studies Advancing Imaging, Biomarkers, and Therapeutic Insights.mp3\u003c\/p\u003e\n\u003cp\u003eDecoding Alpha- and Beta-Cell Function-Human Studies Advancing Imaging, Biomarkers, and Therapeutic Insights.mp4\u003c\/p\u003e\n\u003cp\u003eDecoding Diabetes-AI-Driven Advances in Genetic Research.mp3\u003c\/p\u003e\n\u003cp\u003eDecoding Diabetes-AI-Driven Advances in Genetic Research.mp4\u003c\/p\u003e\n\u003cp\u003eDiabetes and Heart Talk.mp3\u003c\/p\u003e\n\u003cp\u003eDiabetes and Heart Talk.mp4\u003c\/p\u003e\n\u003cp\u003eDiabetes and Peripheral Artery Disease-Evolving Role of GLP-1 RA and New Insights from the STRIDE Trial.mp3\u003c\/p\u003e\n\u003cp\u003eDiabetes and Peripheral Artery Disease-Evolving Role of GLP-1 RA and New Insights from the STRIDE Trial.mp4\u003c\/p\u003e\n\u003cp\u003eDiabetes Care-Let’s Pick Up the Pace-Addressing Inequities in Diabetes Care.mp3\u003c\/p\u003e\n\u003cp\u003eDiabetes Care-Let’s Pick Up the Pace-Addressing Inequities in Diabetes Care.mp4\u003c\/p\u003e\n\u003cp\u003eDiabetic Neuropathy-Unraveling Pain Mechanisms, Systemic Complications, and Innovations in Prevention and Treatmentÿ(With ADA Presidents’ S..mp3\u003c\/p\u003e\n\u003cp\u003eDiabetic Neuropathy-Unraveling Pain Mechanisms, Systemic Complications, and Innovations in Prevention and Treatmentÿ(With ADA Presidents’ S..mp4\u003c\/p\u003e\n\u003cp\u003eDigital Diabetes Education-AI, Social Media, and Innovative Learning for Better Outcomes.mp3\u003c\/p\u003e\n\u003cp\u003eDigital Diabetes Education-AI, Social Media, and Innovative Learning for Better Outcomes.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Behavioral Medicine and Psychology-ABC’s of AI to Support Health Behaviors and Mental Health in Diabetes Care.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Behavioral Medicine and Psychology-ABC’s of AI to Support Health Behaviors and Mental Health in Diabetes Care.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Clinical Centers and Programs-Strengthening the Diabetes Workforce through Training and Certification Opportunities.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Clinical Centers and Programs-Strengthening the Diabetes Workforce through Training and Certification Opportunities.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Diabetes in Youth-D-Tech and DEB-The Spectrum of Disordered Eating Behaviors in Children, Adolescents, and Young Adults Using..mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Diabetes in Youth-D-Tech and DEB-The Spectrum of Disordered Eating Behaviors in Children, Adolescents, and Young Adults Using..mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Diabetes Self-Management Education and Support (DSMES)-Innovations for DSMES- Challenges and Solutions.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Diabetes Self-Management Education and Support (DSMES)-Innovations for DSMES- Challenges and Solutions.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Diabetes Technology-Diabetes Technology Distress.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Diabetes Technology-Diabetes Technology Distress.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Exercise Physiology-Lifestyle Interventions and Cognitive Function.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Exercise Physiology-Lifestyle Interventions and Cognitive Function.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Eye Health-Diabetic Retinopathy-AI Solutions for Screening, Follow-Up, and Workflow Integration.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Eye Health-Diabetic Retinopathy-AI Solutions for Screening, Follow-Up, and Workflow Integration.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Foot Care-Innovations in Limb Salvage-Technology and Amputation Prevention.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Foot Care-Innovations in Limb Salvage-Technology and Amputation Prevention.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Health Care Delivery and Quality Improvement-AI and Machine Learning in Diabetes Management.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Health Care Delivery and Quality Improvement-AI and Machine Learning in Diabetes Management.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Islet Biology, Development, and Function-That Which Does Not Kill You-The Resilient Beta Cell.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Islet Biology, Development, and Function-That Which Does Not Kill You-The Resilient Beta Cell.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Nutritional Science and Metabolism-Climate Change, Nutrition, and Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Nutritional Science and Metabolism-Climate Change, Nutrition, and Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Pregnancy and Reproductive Health-Early Postpartum GDM Screening.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Pregnancy and Reproductive Health-Early Postpartum GDM Screening.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Primary Care-Making the Diagnosis (Did I See a Zebra_).mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Primary Care-Making the Diagnosis (Did I See a Zebra_).mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Public Health and Epidemiology-Diabetes Prevention Across Ages and Settings.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Public Health and Epidemiology-Diabetes Prevention Across Ages and Settings.mp4\u003c\/p\u003e\n\u003cp\u003eDiscussion on Women’s Interprofessional Network of the ADA (WIN ADA)-Sponsoring Women in Diabetes Professions.mp3\u003c\/p\u003e\n\u003cp\u003eDiscussion on Women’s Interprofessional Network of the ADA (WIN ADA)-Sponsoring Women in Diabetes Professions.mp4\u003c\/p\u003e\n\u003cp\u003eDiverse Antigens Targeted in Type 1 Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eDiverse Antigens Targeted in Type 1 Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eEarly Phase, Post Hoc, and Subgroup Analyses from Clinical Trials Testing Incretin-Based Therapies-Take 1.mp3\u003c\/p\u003e\n\u003cp\u003eEarly Phase, Post Hoc, and Subgroup Analyses from Clinical Trials Testing Incretin-Based Therapies-Take 1.mp4\u003c\/p\u003e\n\u003cp\u003eEarly Phase, Post Hoc, and Subgroup Analyses from Clinical Trials with Incretin-Based Therapies-Take 2.mp3\u003c\/p\u003e\n\u003cp\u003eEarly Phase, Post Hoc, and Subgroup Analyses from Clinical Trials with Incretin-Based Therapies-Take 2.mp4\u003c\/p\u003e\n\u003cp\u003eEmerging Biomarkers and Trajectories of ASCVD Risk Progressionÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003c\/p\u003e\n\u003cp\u003eEmerging Biomarkers and Trajectories of ASCVD Risk Progressionÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003c\/p\u003e\n\u003cp\u003eEmerging Mechanisms, Risk Factors, and Cellular Insights in Diabetic Neuropathy and Cognitive Impairment.mp3\u003c\/p\u003e\n\u003cp\u003eEmerging Mechanisms, Risk Factors, and Cellular Insights in Diabetic Neuropathy and Cognitive Impairment.mp4\u003c\/p\u003e\n\u003cp\u003eEmpowering Choice-Nutrition Interventions for Type 2 Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eEmpowering Choice-Nutrition Interventions for Type 2 Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eEmpowering Health Outcomes Utilizing Glooko’s Data Integration.mp3\u003c\/p\u003e\n\u003cp\u003eEmpowering Health Outcomes Utilizing Glooko’s Data Integration.mp4\u003c\/p\u003e\n\u003cp\u003eEmpowering Personalized Diabetes Care, the Next Frontier of Sensing Technology.mp3\u003c\/p\u003e\n\u003cp\u003eEmpowering Personalized Diabetes Care, the Next Frontier of Sensing Technology.mp4\u003c\/p\u003e\n\u003cp\u003eEncapsulation vs. Naked Cell Therapy-Immune Challenges and Beta-Cell Perspectives in Diabetes Treatment.mp3\u003c\/p\u003e\n\u003cp\u003eEncapsulation vs. Naked Cell Therapy-Immune Challenges and Beta-Cell Perspectives in Diabetes Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eEverything You Want to Know about the Latest Advances in Pediatric Type 2 Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eEverything You Want to Know about the Latest Advances in Pediatric Type 2 Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eExercise Types-Mechanisms of Actions and Modeling Effects.mp3\u003c\/p\u003e\n\u003cp\u003eExercise Types-Mechanisms of Actions and Modeling Effects.mp4\u003c\/p\u003e\n\u003cp\u003eExerciseRx-Still Relevant for Diabetes in the Modern Age of Pharmacotherapy_.mp3\u003c\/p\u003e\n\u003cp\u003eExerciseRx-Still Relevant for Diabetes in the Modern Age of Pharmacotherapy_.mp4\u003c\/p\u003e\n\u003cp\u003eExpanding Obesity Therapeutic Options-Preclinical Studies.mp3\u003c\/p\u003e\n\u003cp\u003eExpanding Obesity Therapeutic Options-Preclinical Studies.mp4\u003c\/p\u003e\n\u003cp\u003eExperimental and Multiomic Approaches to Decipher Mechanism of Type 1 and Type 2 Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eExperimental and Multiomic Approaches to Decipher Mechanism of Type 1 and Type 2 Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eExploring Alternative Strategies to Stem Cell-Derived Beta Cells and Insights from Autologous Islet Transplantation.mp3\u003c\/p\u003e\n\u003cp\u003eExploring Alternative Strategies to Stem Cell-Derived Beta Cells and Insights from Autologous Islet Transplantation.mp4\u003c\/p\u003e\n\u003cp\u003eFactors Affecting the Molecular Architecture and Identity of Islet Cells.mp3\u003c\/p\u003e\n\u003cp\u003eFactors Affecting the Molecular Architecture and Identity of Islet Cells.mp4\u003c\/p\u003e\n\u003cp\u003eFood Is Medicine_-Is It a Solution or a Convenient Fix to a Complicated Problem.mp3\u003c\/p\u003e\n\u003cp\u003eFood Is Medicine_-Is It a Solution or a Convenient Fix to a Complicated Problem.mp4\u003c\/p\u003e\n\u003cp\u003eFrom Glucose Streams to Phenotype Dreams-The Future of Continuous Monitoring.mp3\u003c\/p\u003e\n\u003cp\u003eFrom Glucose Streams to Phenotype Dreams-The Future of Continuous Monitoring.mp4\u003c\/p\u003e\n\u003cp\u003eFrom Screening, Telemonitoring, to Care Coordination-Improving Quality.mp3\u003c\/p\u003e\n\u003cp\u003eFrom Screening, Telemonitoring, to Care Coordination-Improving Quality.mp4\u003c\/p\u003e\n\u003cp\u003eFueling the Body-The Complex Interplay of Sugar, Fat, and Protein.mp3\u003c\/p\u003e\n\u003cp\u003eFueling the Body-The Complex Interplay of Sugar, Fat, and Protein.mp4\u003c\/p\u003e\n\u003cp\u003eFuture Ready-Breakthroughs in Pediatric Type 1 Diabetes Care.mp3\u003c\/p\u003e\n\u003cp\u003eFuture Ready-Breakthroughs in Pediatric Type 1 Diabetes Care.mp4\u003c\/p\u003e\n\u003cp\u003eGenes and Microbes-Old Foes and New Revelations on the Road to Type 1 Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eGenes and Microbes-Old Foes and New Revelations on the Road to Type 1 Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eGenetic Regulation of Beta-Cell Mass and Function in Humans-Lessons from GWAS and Rare Genetics.mp3\u003c\/p\u003e\n\u003cp\u003eGenetic Regulation of Beta-Cell Mass and Function in Humans-Lessons from GWAS and Rare Genetics.mp4\u003c\/p\u003e\n\u003cp\u003eGetting the Career You Envision-How to Negotiate For What You Need (And Want).mp3\u003c\/p\u003e\n\u003cp\u003eGetting the Career You Envision-How to Negotiate For What You Need (And Want).mp4\u003c\/p\u003e\n\u003cp\u003eGlobal Diabetes Guidelines-Bridging Borders for Collaborative Care and Shared Insights.mp3\u003c\/p\u003e\n\u003cp\u003eGlobal Diabetes Guidelines-Bridging Borders for Collaborative Care and Shared Insights.mp4\u003c\/p\u003e\n\u003cp\u003eHealth Access Symposium-Community Interventions and Connections.mp3\u003c\/p\u003e\n\u003cp\u003eHealth Access Symposium-Community Interventions and Connections.mp4\u003c\/p\u003e\n\u003cp\u003eHeterogeneity of Diabetes-New Initiatives from NIDDK.mp3\u003c\/p\u003e\n\u003cp\u003eHeterogeneity of Diabetes-New Initiatives from NIDDK.mp4\u003c\/p\u003e\n\u003cp\u003eHiding in Plain Sight-The Need to Address Diabetes Identity in Order to Optimize Outcomes.mp3\u003c\/p\u003e\n\u003cp\u003eHiding in Plain Sight-The Need to Address Diabetes Identity in Order to Optimize Outcomes.mp4\u003c\/p\u003e\n\u003cp\u003eHot Topics in Lipid Management in Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eHot Topics in Lipid Management in Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eHow Can We Better Understand Obesity_ An interactive presentation about obesity and liver health.mp3\u003c\/p\u003e\n\u003cp\u003eHow Can We Better Understand Obesity_ An interactive presentation about obesity and liver health.mp4\u003c\/p\u003e\n\u003cp\u003eHow Point of Care Testing Can Change the Trajectory of Managing Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eHow Point of Care Testing Can Change the Trajectory of Managing Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eImpact of Large-Scale Natural Experiments in Diabetes from the NEXT-D3 Research Network.mp3\u003c\/p\u003e\n\u003cp\u003eImpact of Large-Scale Natural Experiments in Diabetes from the NEXT-D3 Research Network.mp4\u003c\/p\u003e\n\u003cp\u003eImplementing Improvements in Care Delivery.mp3\u003c\/p\u003e\n\u003cp\u003eImplementing Improvements in Care Delivery.mp4\u003c\/p\u003e\n\u003cp\u003eImproving Systems of Care for Diabetes Mellitus.mp3\u003c\/p\u003e\n\u003cp\u003eImproving Systems of Care for Diabetes Mellitus.mp4\u003c\/p\u003e\n\u003cp\u003eIncretin-Based Combination Therapies for Obesity-Clinical Studies.mp3\u003c\/p\u003e\n\u003cp\u003eIncretin-Based Combination Therapies for Obesity-Clinical Studies.mp4\u003c\/p\u003e\n\u003cp\u003eInnovating Stem Cell Manufacturing and Engraftment Strategies for Cell Replacement Therapy.mp3\u003c\/p\u003e\n\u003cp\u003eInnovating Stem Cell Manufacturing and Engraftment Strategies for Cell Replacement Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eInnovation and Progress in Stem Cell-Derived Islet-Cell Replacement Therapy.mp3\u003c\/p\u003e\n\u003cp\u003eInnovation and Progress in Stem Cell-Derived Islet-Cell Replacement Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eInnovation Challenge-Note_ Continuing Education Credit Is Not Awarded for this Session.mp3\u003c\/p\u003e\n\u003cp\u003eInnovation Challenge-Note_ Continuing Education Credit Is Not Awarded for this Session.mp4\u003c\/p\u003e\n\u003cp\u003eInnovative Solutions to the Challenges of Inpatient Diabetes Care and Education-From Hospital to Home.mp3\u003c\/p\u003e\n\u003cp\u003eInnovative Solutions to the Challenges of Inpatient Diabetes Care and Education-From Hospital to Home.mp4\u003c\/p\u003e\n\u003cp\u003eInsulin Action and Its Systemic Effects.mp3\u003c\/p\u003e\n\u003cp\u003eInsulin Action and Its Systemic Effects.mp4\u003c\/p\u003e\n\u003cp\u003eInteroception-Brain-Body Communication Controls Metabolism.mp3\u003c\/p\u003e\n\u003cp\u003eInteroception-Brain-Body Communication Controls Metabolism.mp4\u003c\/p\u003e\n\u003cp\u003eInterventions to Prevent Hypoglycemia-Bench-to-Bedside.mp3\u003c\/p\u003e\n\u003cp\u003eInterventions to Prevent Hypoglycemia-Bench-to-Bedside.mp4\u003c\/p\u003e\n\u003cp\u003eIs There Still a Place for Bariatric Surgery_.mp3\u003c\/p\u003e\n\u003cp\u003eIs There Still a Place for Bariatric Surgery_.mp4\u003c\/p\u003e\n\u003cp\u003eIt’s Complicated-Diabetes Profiles, Pathways, and Problems.mp3\u003c\/p\u003e\n\u003cp\u003eIt’s Complicated-Diabetes Profiles, Pathways, and Problems.mp4\u003c\/p\u003e\n\u003cp\u003eJoint ADA_AACC Symposium-1 Hour Glucose to Diagnose Intermediate Hyperglycemia and Diabetes. Do We Need Another Test_.mp3\u003c\/p\u003e\n\u003cp\u003eJoint ADA_AACC Symposium-1 Hour Glucose to Diagnose Intermediate Hyperglycemia and Diabetes. Do We Need Another Test_.mp4\u003c\/p\u003e\n\u003cp\u003eJoint ADA_IPITA Symposium-Outpacing the Immune System-Sprinting towards Immune Protection for Cell Replacement Therapy.mp3\u003c\/p\u003e\n\u003cp\u003eJoint ADA_IPITA Symposium-Outpacing the Immune System-Sprinting towards Immune Protection for Cell Replacement Therapy.mp4\u003c\/p\u003e\n\u003cp\u003eJoint ADA_ISPAD Symposium-Exploring Emerging Treatments for Pediatric Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eJoint ADA_ISPAD Symposium-Exploring Emerging Treatments for Pediatric Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eKelly West Award for Outstanding Achievement in Epidemiology Lecture.mp3\u003c\/p\u003e\n\u003cp\u003eKelly West Award for Outstanding Achievement in Epidemiology Lecture.mp4\u003c\/p\u003e\n\u003cp\u003eLancet Journal Symposium-Early-Onset Type 2 Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eLancet Journal Symposium-Early-Onset Type 2 Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eLeveraging Population Diversity to Improve Understanding of the Genetic Etiology of Type 1 and Type 2 Diabetesÿ(With ADA Presidents’ Select..mp3\u003c\/p\u003e\n\u003cp\u003eLeveraging Population Diversity to Improve Understanding of the Genetic Etiology of Type 1 and Type 2 Diabetesÿ(With ADA Presidents’ Select..mp4\u003c\/p\u003e\n\u003cp\u003eLeveraging Technology and Access to Improve Diabetic Foot Care (With Roger Pecoraro Award Lecture).mp3\u003c\/p\u003e\n\u003cp\u003eLeveraging Technology and Access to Improve Diabetic Foot Care (With Roger Pecoraro Award Lecture).mp4\u003c\/p\u003e\n\u003cp\u003eLife with diabetes just got easier.mp3\u003c\/p\u003e\n\u003cp\u003eLife with diabetes just got easier.mp4\u003c\/p\u003e\n\u003cp\u003eLiver at the Crossroads-From Molecules to Mechanisms of Metabolic Healthÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003c\/p\u003e\n\u003cp\u003eLiver at the Crossroads-From Molecules to Mechanisms of Metabolic Healthÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003c\/p\u003e\n\u003cp\u003eMaternal and Child Health-Exploring Nutrition, Metabolism, and Genetic Influencesÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003c\/p\u003e\n\u003cp\u003eMaternal and Child Health-Exploring Nutrition, Metabolism, and Genetic Influencesÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003c\/p\u003e\n\u003cp\u003eMaximizing Impact-Cost-Effectiveness and Real-World Outcomes of AI-Enabled Diabetic Retinopathy Screening Programs.mp3\u003c\/p\u003e\n\u003cp\u003eMaximizing Impact-Cost-Effectiveness and Real-World Outcomes of AI-Enabled Diabetic Retinopathy Screening Programs.mp4\u003c\/p\u003e\n\u003cp\u003eMechanisms Linking Adipose Health with Lipid and Glucose Homeostasis.mp3\u003c\/p\u003e\n\u003cp\u003eMechanisms Linking Adipose Health with Lipid and Glucose Homeostasis.mp4\u003c\/p\u003e\n\u003cp\u003eMechanistic Insights into Diabetic Kidney Disease-Top Research Abstracts.mp3\u003c\/p\u003e\n\u003cp\u003eMechanistic Insights into Diabetic Kidney Disease-Top Research Abstracts.mp4\u003c\/p\u003e\n\u003cp\u003eMechanistic Insights into Metabolic Dysfunction in the Liver.mp3\u003c\/p\u003e\n\u003cp\u003eMechanistic Insights into Metabolic Dysfunction in the Liver.mp4\u003c\/p\u003e\n\u003cp\u003eMechanistic Insights on Gestational Diabetes and Its Consequencesÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003c\/p\u003e\n\u003cp\u003eMechanistic Insights on Gestational Diabetes and Its Consequencesÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003c\/p\u003e\n\u003cp\u003eMedications Effects on the Kidney, Liver, and Epicardium in Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eMedications Effects on the Kidney, Liver, and Epicardium in Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eMetabolic and Molecular Characteristics of MASH.mp3\u003c\/p\u003e\n\u003cp\u003eMetabolic and Molecular Characteristics of MASH.mp4\u003c\/p\u003e\n\u003cp\u003eMetabolic Cross Talk and Endocrine Signaling.mp3\u003c\/p\u003e\n\u003cp\u003eMetabolic Cross Talk and Endocrine Signaling.mp4\u003c\/p\u003e\n\u003cp\u003eMetabolic Mediators of Metabolic Wasting.mp3\u003c\/p\u003e\n\u003cp\u003eMetabolic Mediators of Metabolic Wasting.mp4\u003c\/p\u003e\n\u003cp\u003eMetabolic Regulations of Early Worsening and Protection from Diabetic Eye Disease.mp3\u003c\/p\u003e\n\u003cp\u003eMetabolic Regulations of Early Worsening and Protection from Diabetic Eye Disease.mp4\u003c\/p\u003e\n\u003cp\u003eMicrobiota and Immune Interactions in Early Life-Impact on Health and Disease.mp3\u003c\/p\u003e\n\u003cp\u003eMicrobiota and Immune Interactions in Early Life-Impact on Health and Disease.mp4\u003c\/p\u003e\n\u003cp\u003eMolecular and Cellular Mechanisms Driving Muscle Atrophy and Dysfunction.mp3\u003c\/p\u003e\n\u003cp\u003eMolecular and Cellular Mechanisms Driving Muscle Atrophy and Dysfunction.mp4\u003c\/p\u003e\n\u003cp\u003eMolecular and Metabolic Mechanisms in Diabetic Retinopathy.mp3\u003c\/p\u003e\n\u003cp\u003eMolecular and Metabolic Mechanisms in Diabetic Retinopathy.mp4\u003c\/p\u003e\n\u003cp\u003eMolecular Regulation of Muscle Function and Insulin Sensitivity.mp3\u003c\/p\u003e\n\u003cp\u003eMolecular Regulation of Muscle Function and Insulin Sensitivity.mp4\u003c\/p\u003e\n\u003cp\u003eMounjaror (tirzepatide) Product Theater.mp3\u003c\/p\u003e\n\u003cp\u003eMounjaror (tirzepatide) Product Theater.mp4\u003c\/p\u003e\n\u003cp\u003eMuscle and Energy Expenditure-Myths, Legends, and Facts.mp3\u003c\/p\u003e\n\u003cp\u003eMuscle and Energy Expenditure-Myths, Legends, and Facts.mp4\u003c\/p\u003e\n\u003cp\u003eNational Scientific \u0026amp; Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture.mp3\u003c\/p\u003e\n\u003cp\u003eNational Scientific \u0026amp; Health Care Achievement Awards Presentation and Outstanding Scientific Achievement Award Lecture.mp4\u003c\/p\u003e\n\u003cp\u003eNeuropathy Potpourri-Unveiling Novel Mechanisms and Urogenital Autonomic Dysfunction Impacts.mp3\u003c\/p\u003e\n\u003cp\u003eNeuropathy Potpourri-Unveiling Novel Mechanisms and Urogenital Autonomic Dysfunction Impacts.mp4\u003c\/p\u003e\n\u003cp\u003eNeurotransmission in the Islet-From Outside to Inside.mp3\u003c\/p\u003e\n\u003cp\u003eNeurotransmission in the Islet-From Outside to Inside.mp4\u003c\/p\u003e\n\u003cp\u003eNew Approaches to Detect and Monitor Diabetes in Pregnancy.mp3\u003c\/p\u003e\n\u003cp\u003eNew Approaches to Detect and Monitor Diabetes in Pregnancy.mp4\u003c\/p\u003e\n\u003cp\u003eNew Molecular Pathways of Thermogenesis.mp3\u003c\/p\u003e\n\u003cp\u003eNew Molecular Pathways of Thermogenesis.mp4\u003c\/p\u003e\n\u003cp\u003eNew Molecular Regulators of Energy Metabolism Independent of Appetite Suppression.mp3\u003c\/p\u003e\n\u003cp\u003eNew Molecular Regulators of Energy Metabolism Independent of Appetite Suppression.mp4\u003c\/p\u003e\n\u003cp\u003eNew Perspectives on Fetal and Placental Responses to Diabetes and Its Treatment.mp3\u003c\/p\u003e\n\u003cp\u003eNew Perspectives on Fetal and Placental Responses to Diabetes and Its Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eNew Technologies to Address Old Questions in Molecular Metabolism.mp3\u003c\/p\u003e\n\u003cp\u003eNew Technologies to Address Old Questions in Molecular Metabolism.mp4\u003c\/p\u003e\n\u003cp\u003eNew-and Surprising-Ways to Lower Glucose in Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eNew-and Surprising-Ways to Lower Glucose in Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eNext Generation Therapies for Type 2 Diabetes and Obesity.mp3\u003c\/p\u003e\n\u003cp\u003eNext Generation Therapies for Type 2 Diabetes and Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eNIDDK Early Career Investigator Symposium-Neuroscience and Diabetes-Innovations Across the Translational Science Spectrum.mp3\u003c\/p\u003e\n\u003cp\u003eNIDDK Early Career Investigator Symposium-Neuroscience and Diabetes-Innovations Across the Translational Science Spectrum.mp4\u003c\/p\u003e\n\u003cp\u003eNonneuronal Contributors to CNS Regulation of Body Weight.mp3\u003c\/p\u003e\n\u003cp\u003eNonneuronal Contributors to CNS Regulation of Body Weight.mp4\u003c\/p\u003e\n\u003cp\u003eNot All Obesity is the Same – a Look at Obesities caused by Rare Neuro-endocrine diseases.mp3\u003c\/p\u003e\n\u003cp\u003eNot All Obesity is the Same – a Look at Obesities caused by Rare Neuro-endocrine diseases.mp4\u003c\/p\u003e\n\u003cp\u003eNot Just a Consequence of Glycemic Management-The Multifaceted Harms of Treatment-Induced Hypoglycemia.mp3\u003c\/p\u003e\n\u003cp\u003eNot Just a Consequence of Glycemic Management-The Multifaceted Harms of Treatment-Induced Hypoglycemia.mp4\u003c\/p\u003e\n\u003cp\u003eNovel Insights into the Effects of Glucose-Lowering and Statin Drugs on Development of ASCVD.mp3\u003c\/p\u003e\n\u003cp\u003eNovel Insights into the Effects of Glucose-Lowering and Statin Drugs on Development of ASCVD.mp4\u003c\/p\u003e\n\u003cp\u003eNovel Nonpharmacologic Interventions to Modulate Insulin Resistance.mp3\u003c\/p\u003e\n\u003cp\u003eNovel Nonpharmacologic Interventions to Modulate Insulin Resistance.mp4\u003c\/p\u003e\n\u003cp\u003eOld Dog, New Tricks_ Making Sense of the New Research in Care Delivery.mp3\u003c\/p\u003e\n\u003cp\u003eOld Dog, New Tricks_ Making Sense of the New Research in Care Delivery.mp4\u003c\/p\u003e\n\u003cp\u003eOpening a Door to Precision Medicine-Lessons from Human Kidney Tissue in Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eOpening a Door to Precision Medicine-Lessons from Human Kidney Tissue in Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eOver-the-Counter Continuous Glucose Monitoring-Data for All or a Disaster Waiting to Happen_.mp3\u003c\/p\u003e\n\u003cp\u003eOver-the-Counter Continuous Glucose Monitoring-Data for All or a Disaster Waiting to Happen_.mp4\u003c\/p\u003e\n\u003cp\u003ePATHWEIGH Trial-Building the Highway for Weight Management in Primary Care.mp3\u003c\/p\u003e\n\u003cp\u003ePATHWEIGH Trial-Building the Highway for Weight Management in Primary Care.mp4\u003c\/p\u003e\n\u003cp\u003ePerspective Panel-Dropping Cost and Complications-CVD Risk and DM-SGLT2s and GLPs for CVD.mp3\u003c\/p\u003e\n\u003cp\u003ePerspective Panel-Dropping Cost and Complications-CVD Risk and DM-SGLT2s and GLPs for CVD.mp4\u003c\/p\u003e\n\u003cp\u003ePhysical Activity-Barriers, Facilitators, and Key Outcomes.mp3\u003c\/p\u003e\n\u003cp\u003ePhysical Activity-Barriers, Facilitators, and Key Outcomes.mp4\u003c\/p\u003e\n\u003cp\u003ePhysiologic Adaptations to Exercise in Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003ePhysiologic Adaptations to Exercise in Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003ePhysiologic Underpinnings behind New Therapies for MASLD and Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003ePhysiologic Underpinnings behind New Therapies for MASLD and Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003ePolygenic Scores in Research, Clinical Classification, and Prediction-Opportunities and Hurdles for Translation.mp3\u003c\/p\u003e\n\u003cp\u003ePolygenic Scores in Research, Clinical Classification, and Prediction-Opportunities and Hurdles for Translation.mp4\u003c\/p\u003e\n\u003cp\u003ePresident, Medicine \u0026amp; Science Address and Banting Medal for Scientific Achievement.mp3\u003c\/p\u003e\n\u003cp\u003ePresident, Medicine \u0026amp; Science Address and Banting Medal for Scientific Achievement.mp4\u003c\/p\u003e\n\u003cp\u003eProduct Theater for Zepboundr (tirzepatide) Injection.mp3\u003c\/p\u003e\n\u003cp\u003eProduct Theater for Zepboundr (tirzepatide) Injection.mp4\u003c\/p\u003e\n\u003cp\u003eProglucagon Peptide Cross Talk.mp3\u003c\/p\u003e\n\u003cp\u003eProglucagon Peptide Cross Talk.mp4\u003c\/p\u003e\n\u003cp\u003eRe-examining the Dogma of the Dietary Treatment of Non-Severe Hypoglycemia-Does the Rule of 15 Still Apply_.mp3\u003c\/p\u003e\n\u003cp\u003eRe-examining the Dogma of the Dietary Treatment of Non-Severe Hypoglycemia-Does the Rule of 15 Still Apply_.mp4\u003c\/p\u003e\n\u003cp\u003eReady for Prime Time_-Pharmacoepidemiology and Real-World Evidence.mp3\u003c\/p\u003e\n\u003cp\u003eReady for Prime Time_-Pharmacoepidemiology and Real-World Evidence.mp4\u003c\/p\u003e\n\u003cp\u003eReady, Set, Go-Outcomes of Behavioral Transition Interventions for Adolescents and Young Adults with Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eReady, Set, Go-Outcomes of Behavioral Transition Interventions for Adolescents and Young Adults with Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eReal-World Automated Insulin Delivery System Results.mp3\u003c\/p\u003e\n\u003cp\u003eReal-World Automated Insulin Delivery System Results.mp4\u003c\/p\u003e\n\u003cp\u003eRemembering Type 1 Diabetes in the Kidney Therapeutics Revolution.mp3\u003c\/p\u003e\n\u003cp\u003eRemembering Type 1 Diabetes in the Kidney Therapeutics Revolution.mp4\u003c\/p\u003e\n\u003cp\u003eRising Risks, Real Solutions-Tackling Childhood Type 2 Diabetes and Obesity.mp3\u003c\/p\u003e\n\u003cp\u003eRising Risks, Real Solutions-Tackling Childhood Type 2 Diabetes and Obesity.mp4\u003c\/p\u003e\n\u003cp\u003eSaving Kidneys and Lives Ushers in a New Era for Kidney Disease in Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eSaving Kidneys and Lives Ushers in a New Era for Kidney Disease in Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eScreen, Stage, and Manage Type 1 Diabetes_ A Proactive Approach to Care.mp3\u003c\/p\u003e\n\u003cp\u003eScreen, Stage, and Manage Type 1 Diabetes_ A Proactive Approach to Care.mp4\u003c\/p\u003e\n\u003cp\u003eScreening and Primary Prevention Strategies for ASCVD in Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eScreening and Primary Prevention Strategies for ASCVD in Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eSetting the Standard with Omnipod 5_ Remarkable Results with Unmatched Simplicity.mp3\u003c\/p\u003e\n\u003cp\u003eSetting the Standard with Omnipod 5_ Remarkable Results with Unmatched Simplicity.mp4\u003c\/p\u003e\n\u003cp\u003eShared Genetic Etiologies between Type 2 Diabetes and Related Complications and Comorbidities.mp3\u003c\/p\u003e\n\u003cp\u003eShared Genetic Etiologies between Type 2 Diabetes and Related Complications and Comorbidities.mp4\u003c\/p\u003e\n\u003cp\u003eShow Me the Data! Using Continuous Glucose Monitoring Data to Drive Behavior Change.mp3\u003c\/p\u003e\n\u003cp\u003eShow Me the Data! Using Continuous Glucose Monitoring Data to Drive Behavior Change.mp4\u003c\/p\u003e\n\u003cp\u003eSip and Chat 1.mp3\u003c\/p\u003e\n\u003cp\u003eSip and Chat 1.mp4\u003c\/p\u003e\n\u003cp\u003eSip and Chat 2.mp3\u003c\/p\u003e\n\u003cp\u003eSip and Chat 2.mp4\u003c\/p\u003e\n\u003cp\u003eSo Long Prediabetes and Its Complications!ÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003c\/p\u003e\n\u003cp\u003eSo Long Prediabetes and Its Complications!ÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003c\/p\u003e\n\u003cp\u003eSOUL Trial-Effects of Oral Semaglutide on Cardiovascular (and Other) Outcomes in People with Type 2 Diabetes at High CV Risk.mp3\u003c\/p\u003e\n\u003cp\u003eSOUL Trial-Effects of Oral Semaglutide on Cardiovascular (and Other) Outcomes in People with Type 2 Diabetes at High CV Risk.mp4\u003c\/p\u003e\n\u003cp\u003eStandards of Care in Diabetes 2025 Updates.mp3\u003c\/p\u003e\n\u003cp\u003eStandards of Care in Diabetes 2025 Updates.mp4\u003c\/p\u003e\n\u003cp\u003eStandards of Care in Overweight and Obesity 2025 Updates.mp3\u003c\/p\u003e\n\u003cp\u003eStandards of Care in Overweight and Obesity 2025 Updates.mp4\u003c\/p\u003e\n\u003cp\u003eStates of the Beta Cell.mp3\u003c\/p\u003e\n\u003cp\u003eStates of the Beta Cell.mp4\u003c\/p\u003e\n\u003cp\u003eStrategies for Early CKD Identification, Diagnosis, and Evidence-Based Treatment.mp3\u003c\/p\u003e\n\u003cp\u003eStrategies for Early CKD Identification, Diagnosis, and Evidence-Based Treatment.mp4\u003c\/p\u003e\n\u003cp\u003eTailoring Diabetes Education to Real-World Challenges.mp3\u003c\/p\u003e\n\u003cp\u003eTailoring Diabetes Education to Real-World Challenges.mp4\u003c\/p\u003e\n\u003cp\u003eTake Me to the River-Is Islet Blood Flow Closed and Active, or Integrated and Passive_.mp3\u003c\/p\u003e\n\u003cp\u003eTake Me to the River-Is Islet Blood Flow Closed and Active, or Integrated and Passive_.mp4\u003c\/p\u003e\n\u003cp\u003eThe Cost Chiasm-Therapeutics, Technologies, and Careÿ(With ADA Presidents’ Select Abstract Presentation).mp3\u003c\/p\u003e\n\u003cp\u003eThe Cost Chiasm-Therapeutics, Technologies, and Careÿ(With ADA Presidents’ Select Abstract Presentation).mp4\u003c\/p\u003e\n\u003cp\u003eThe Elephant in the Room-How to Address Hypertriglyceridemia in Diabetes_.mp3\u003c\/p\u003e\n\u003cp\u003eThe Elephant in the Room-How to Address Hypertriglyceridemia in Diabetes_.mp4\u003c\/p\u003e\n\u003cp\u003eThe Future of Weight Loss Therapies-Food Intake Versus Energy Expenditure.mp3\u003c\/p\u003e\n\u003cp\u003eThe Future of Weight Loss Therapies-Food Intake Versus Energy Expenditure.mp4\u003c\/p\u003e\n\u003cp\u003eThe Golden Oldies in Diabetes Management.mp3\u003c\/p\u003e\n\u003cp\u003eThe Golden Oldies in Diabetes Management.mp4\u003c\/p\u003e\n\u003cp\u003eThe Hypoglycemia Risk Profile-Leveraging Disparate Methods to Identify and Phenotype Those at Risk.mp3\u003c\/p\u003e\n\u003cp\u003eThe Hypoglycemia Risk Profile-Leveraging Disparate Methods to Identify and Phenotype Those at Risk.mp4\u003c\/p\u003e\n\u003cp\u003eThe Islet Facing Adversity-Adaptive Mechanisms.mp3\u003c\/p\u003e\n\u003cp\u003eThe Islet Facing Adversity-Adaptive Mechanisms.mp4\u003c\/p\u003e\n\u003cp\u003eThe Next Era In The Treatment Of Hypertension.mp3\u003c\/p\u003e\n\u003cp\u003eThe Next Era In The Treatment Of Hypertension.mp4\u003c\/p\u003e\n\u003cp\u003eThe Overlooked Organ-Optimizing Liver Health in Diabetes Management.mp3\u003c\/p\u003e\n\u003cp\u003eThe Overlooked Organ-Optimizing Liver Health in Diabetes Management.mp4\u003c\/p\u003e\n\u003cp\u003eThe Tidal Wave Is Coming-Heart Failure Diagnosis, Prevention, and Treatment in Patients with Type 2 Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eThe Tidal Wave Is Coming-Heart Failure Diagnosis, Prevention, and Treatment in Patients with Type 2 Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eTiming Is Everything-Circadian Rhythms in Health and Disease.mp3\u003c\/p\u003e\n\u003cp\u003eTiming Is Everything-Circadian Rhythms in Health and Disease.mp4\u003c\/p\u003e\n\u003cp\u003eTraditional and Emerging Therapeutic Methods for Lipid Management in Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eTraditional and Emerging Therapeutic Methods for Lipid Management in Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eTranscriptional and Posttranslational Mechanisms in Metabolic Control.mp3\u003c\/p\u003e\n\u003cp\u003eTranscriptional and Posttranslational Mechanisms in Metabolic Control.mp4\u003c\/p\u003e\n\u003cp\u003eTranslational and Human Studies on Metabolic Regulation.mp3\u003c\/p\u003e\n\u003cp\u003eTranslational and Human Studies on Metabolic Regulation.mp4\u003c\/p\u003e\n\u003cp\u003eTrending Topics and Smart Solutions in Pediatric Diabetes.mp3\u003c\/p\u003e\n\u003cp\u003eTrending Topics and Smart Solutions in Pediatric Diabetes.mp4\u003c\/p\u003e\n\u003cp\u003eUnder the Knife-Perioperative Considerations for Patients with Diabetic Foot Infections.mp3\u003c\/p\u003e\n\u003cp\u003eUnder the Knife-Perioperative Considerations for Patients with Diabetic Foot Infections.mp4\u003c\/p\u003e\n\u003cp\u003eUnderstanding the Type 1 Diabetes Journey_ The Importance of Early Detection.mp3\u003c\/p\u003e\n\u003cp\u003eUnderstanding the Type 1 Diabetes Journey_ The Importance of Early Detection.mp4\u003c\/p\u003e\n\u003cp\u003eUnraveling the Code-Multiomic Insights into Diabetic Foot Ulcer Healing.mp3\u003c\/p\u003e\n\u003cp\u003eUnraveling the Code-Multiomic Insights into Diabetic Foot Ulcer Healing.mp4\u003c\/p\u003e\n\u003cp\u003eUnraveling the Secrets of Energy, Appetite, and Sugar Control.mp3\u003c\/p\u003e\n\u003cp\u003eUnraveling the Secrets of Energy, Appetite, and Sugar Control.mp4\u003c\/p\u003e\n\u003cp\u003eUse of Diabetes Technology in Outpatient Pregnancy Management.mp3\u003c\/p\u003e\n\u003cp\u003eUse of Diabetes Technology in Outpatient Pregnancy Management.mp4\u003c\/p\u003e\n\u003cp\u003eUse of GLP-1RAs and SGLT2i with Automated Insulin Delivery Systems.mp3\u003c\/p\u003e\n\u003cp\u003eUse of GLP-1RAs and SGLT2i with Automated Insulin Delivery Systems.mp4\u003c\/p\u003e\n\u003cp\u003eWeight Bias.mp3\u003c\/p\u003e\n\u003cp\u003eWeight Bias.mp4\u003c\/p\u003e\n\u003cp\u003eWeight Loss in Pregnancy with Obesity-Risky Gamble or Beneficial Bet_.mp3\u003c\/p\u003e\n\u003cp\u003eWeight Loss in Pregnancy with Obesity-Risky Gamble or Beneficial Bet_.mp4\u003c\/p\u003e\n\u003cp\u003eWelcome to the 85th ADA Scientific Sessions \u0026amp; ‘Pathway to Stop Diabetes’.mp3\u003c\/p\u003e\n\u003cp\u003eWelcome to the 85th ADA Scientific Sessions \u0026amp; ‘Pathway to Stop Diabetes’.mp4\u003c\/p\u003e\n\u003cp\u003eWhat Is the Best Way to Measure the Burden and Severity of Hypoglycemia in People Living with Diabetes_.mp3\u003c\/p\u003e\n\u003cp\u003eWhat Is the Best Way to Measure the Burden and Severity of Hypoglycemia in People Living with Diabetes_.mp4\u003c\/p\u003e\n\u003cp\u003eWhat Is the Real Molecular Target(s) of Metformin_.mp3\u003c\/p\u003e\n\u003cp\u003eWhat Is the Real Molecular Target(s) of Metformin_.mp4\u003c\/p\u003e\n\u003cp\u003eWhat’s New with Automated Insulin Delivery_.mp3\u003c\/p\u003e\n\u003cp\u003eWhat’s New with Automated Insulin Delivery_.mp4\u003c\/p\u003e\n\u003cp\u003eWhat’s New with Continuous Glucose Monitoring_.mp3\u003c\/p\u003e\n\u003cp\u003eWhat’s New with Continuous Glucose Monitoring_.mp4\u003c\/p\u003e\n\u003cp\u003eWhat’s New with Interpretation of CGM Metrics and Relationship to A1C, eA1C and GMI_.mp3\u003c\/p\u003e\n\u003cp\u003eWhat’s New with Interpretation of CGM Metrics and Relationship to A1C, eA1C and GMI_.mp4\u003c\/p\u003e\n\u003cp\u003eWhen the Treatment of Type 2 Diabetes Becomes Nuanced.mp3\u003c\/p\u003e\n\u003cp\u003eWhen the Treatment of Type 2 Diabetes Becomes Nuanced.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405773033668,"sku":null,"price":117.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/American-Diabetes-Association-85th-Scientific-Sessions-2025-scaled.png?v=1784215935","url":"https:\/\/medicalcoursespro.com\/products\/american-diabetes-association-85th-scientific-sessions-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}